SK283205B6 - Použitie selegilínu na ošetrovanie epileptických ochorení - Google Patents

Použitie selegilínu na ošetrovanie epileptických ochorení Download PDF

Info

Publication number
SK283205B6
SK283205B6 SK199-97A SK19997A SK283205B6 SK 283205 B6 SK283205 B6 SK 283205B6 SK 19997 A SK19997 A SK 19997A SK 283205 B6 SK283205 B6 SK 283205B6
Authority
SK
Slovakia
Prior art keywords
selegiline
epileptic
treatment
action
convulsions
Prior art date
Application number
SK199-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK19997A3 (en
Inventor
Wolfgang L�Scher
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of SK19997A3 publication Critical patent/SK19997A3/sk
Publication of SK283205B6 publication Critical patent/SK283205B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK199-97A 1994-08-11 1995-07-27 Použitie selegilínu na ošetrovanie epileptických ochorení SK283205B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428444A DE4428444A1 (de) 1994-08-11 1994-08-11 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
PCT/DE1995/000981 WO1996004897A1 (de) 1994-08-11 1995-07-27 Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Publications (2)

Publication Number Publication Date
SK19997A3 SK19997A3 (en) 1997-08-06
SK283205B6 true SK283205B6 (sk) 2003-03-04

Family

ID=6525440

Family Applications (1)

Application Number Title Priority Date Filing Date
SK199-97A SK283205B6 (sk) 1994-08-11 1995-07-27 Použitie selegilínu na ošetrovanie epileptických ochorení

Country Status (23)

Country Link
US (1) US5952388A (hu)
EP (1) EP0774961B1 (hu)
JP (1) JP3922307B2 (hu)
CN (1) CN1081918C (hu)
AT (1) ATE239458T1 (hu)
AU (1) AU691316B2 (hu)
BR (1) BR9508531A (hu)
CA (1) CA2197176C (hu)
CZ (1) CZ285681B6 (hu)
DE (2) DE4428444A1 (hu)
DK (1) DK0774961T3 (hu)
EE (1) EE04176B1 (hu)
ES (1) ES2199252T3 (hu)
HU (1) HU223529B1 (hu)
MY (1) MY116362A (hu)
NO (1) NO314684B1 (hu)
PL (1) PL188040B1 (hu)
PT (1) PT774961E (hu)
RU (1) RU2155584C2 (hu)
SK (1) SK283205B6 (hu)
TR (1) TR199500984A2 (hu)
TW (1) TW448044B (hu)
WO (1) WO1996004897A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
EP1441708B1 (en) 2001-11-05 2009-04-08 Krele Pharmaceuticals LLC Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
GB201715919D0 (en) * 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
AU1450592A (en) * 1991-04-04 1992-11-02 University Of Toronto Innovations Foundation, The Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5648087A (en) * 1993-03-09 1997-07-15 Sanofi Sante Nutrition Animale Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition

Also Published As

Publication number Publication date
CN1155241A (zh) 1997-07-23
MX9701031A (es) 1998-05-31
DE4428444A1 (de) 1996-02-15
EP0774961A1 (de) 1997-05-28
HUT77175A (hu) 1998-03-02
TR199500984A2 (tr) 1996-06-21
JP3922307B2 (ja) 2007-05-30
PL318292A1 (en) 1997-06-09
ES2199252T3 (es) 2004-02-16
CZ40797A3 (en) 1997-07-16
CA2197176C (en) 2007-06-26
EE9700068A (et) 1997-10-15
NO970607L (no) 1997-02-10
NO970607D0 (no) 1997-02-10
TW448044B (en) 2001-08-01
CN1081918C (zh) 2002-04-03
NO314684B1 (no) 2003-05-05
PL188040B1 (pl) 2004-11-30
AU691316B2 (en) 1998-05-14
BR9508531A (pt) 1998-12-01
MY116362A (en) 2004-01-31
DE59510674D1 (de) 2003-06-12
ATE239458T1 (de) 2003-05-15
CA2197176A1 (en) 1996-02-22
US5952388A (en) 1999-09-14
CZ285681B6 (cs) 1999-10-13
JPH10504029A (ja) 1998-04-14
WO1996004897A1 (de) 1996-02-22
RU2155584C2 (ru) 2000-09-10
PT774961E (pt) 2003-09-30
EP0774961B1 (de) 2003-05-07
HU223529B1 (hu) 2004-08-30
EE04176B1 (et) 2003-12-15
SK19997A3 (en) 1997-08-06
AU2976095A (en) 1996-03-07
DK0774961T3 (da) 2003-09-01

Similar Documents

Publication Publication Date Title
DE69330387T2 (de) Amantadine und verwandte Verbindungen zur Anwendung zur Behandlung von Neuropathie
US4988710A (en) Aryl-cycloalkyl-alkanolamines for treatment of cholinergic neurotoxins
DE60121301T2 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
US4496545A (en) Nonapeptide for treating addictive drug withdrawal conditions
JPH07173056A (ja) 精神病治療薬としての4−フェニル−1,2,3,4−テトラヒドロ−1−ナフタレンアミン誘導体の使用
CA2212412A1 (en) Deprenyl compounds for treatment of glaucoma
SK61398A3 (en) Use of epinastine in the treatment of pain
Bonta et al. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases
DE19539861A1 (de) Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
EP0284621A1 (en) PSYCHOSTIMULATING AGENT.
CA2320992A1 (en) Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith
SK283205B6 (sk) Použitie selegilínu na ošetrovanie epileptických ochorení
US4945097A (en) Aryl-cycloalkyl-alkanolamines for treatment of neurotoxic injury
EP0214933A2 (de) Kombinationspräparate zur Behandlung von Malaria
DE69921137T2 (de) Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster
JP3865450B2 (ja) パーキンソニズム治療剤
RU2184542C2 (ru) Гидрохлорид 1-фенил-1-циклопентил-4-пиперидино-2-бутин-1-ола (пентифин), обладающий активностью при лечении и предупреждении паркинсонизма
RU2223756C1 (ru) Способ лечения рецидивирующего иридоциклохориоидита лошадей
SU1703110A1 (ru) Средство дл лечени отравлений, вызванных м-холинолитическими средствами
MXPA97001031A (en) Utilization of selegiline for the treatment of epilepti diseases
DE1670061C (de) 2 (2' Pyndyloxy)-athylguamdin und Verfahren zu dessen Herstellung
DE102006028371A1 (de) Mittel gegen Malaria
Leszkovszky et al. The central nervous effects of bis-(4-aminophenyl)-alkyl derivatives
AU2003268857A1 (en) Deprenyl compounds for treatment of glaucoma
WO2000066105A9 (en) Treatment of epilepsy with imino sugars

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100727